Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy.
Chou, Cassie K
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. [electronic resource] - Expert opinion on biological therapy 06 2020 - 653-664 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1744-7682
10.1080/14712598.2020.1729735 doi
Adrenal Cortex Hormones--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Antigens, CD19--immunology
Cytokine Release Syndrome--drug therapy
Humans
Immunotherapy, Adoptive--adverse effects
Neurotoxicity Syndromes--drug therapy
Risk Factors
Severity of Illness Index
Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. [electronic resource] - Expert opinion on biological therapy 06 2020 - 653-664 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1744-7682
10.1080/14712598.2020.1729735 doi
Adrenal Cortex Hormones--therapeutic use
Antibodies, Monoclonal, Humanized--therapeutic use
Antigens, CD19--immunology
Cytokine Release Syndrome--drug therapy
Humans
Immunotherapy, Adoptive--adverse effects
Neurotoxicity Syndromes--drug therapy
Risk Factors
Severity of Illness Index